background preloader


Facebook Twitter

Ministerio de Sanidad, Consumo y Bienestar Social - Profesionales - Enfermedad por nuevo coronavirus, COVID-19. LitCovid - NCBI - NLM - NIH. Informes COVID-19. Inicio de sesión.

Informes COVID-19

Guía COVID 10 03. Biblioteca Médica Virtual – Blog. Epistemonikos -tto COVID Living Overview of the Evidence (L·OVE) BMJ Coronavirus (covid-19): Latest news and resources. JAMA COVID19. [Skip to Content] [Skip to Content Landing] Coronavirus (COVID19) Check here for the latest on COVID-19 diagnosis and treatment Add to My Interests All Apply All Article Types Next 20 Results » open access Trending Select Your Interests.


Lancet COVID-19 Resource Centre. NEJM Coronavirus (Covid-19) Cochrane COVID 19 resources and news. Cochrane provides high-quality, relevant, and up-to-date synthesized research evidence to inform health decisions.

Cochrane COVID 19 resources and news

This page highlights content relating to the coronavirus (COVID-19) pandemic and the various related activities that Cochrane is undertaking in response. We will be continually adding updates and additions to this page. Sections include information and resources for: Latest news: Updated 2 April: Added in the Evidently Cochrane blog post 'Health advice in the media: how do we know what to believe? Cochrane COVID Rapid Reviews. All questions submitted by stakeholders and users have been collated and published here, including those relating to rapid reviews that are already being conducted.

Cochrane COVID Rapid Reviews

We are making every effort to keep the list up to date as new questions are submitted and work initiated, and as question refinement and prioritisation progresses over the coming days and weeks. If you are aware that any of these questions are already underway by researchers elsewhere, please email and we will do what we can to prevent duplication of effort. If you are interested in conducting a COVID Rapid Review to address one of the questions, please read the information about conducting a COVID Rapid Review. If a question you consider to be a priority is not in the Question Bank, you can submit it here. Cochrane Iberoamérica. NICE COVID-19. ASM American Society of Microbiology COVID-19 Resources. Background: A new strain of coronavirus causing pneumonia-like symptoms was recently identified in Wuhan, China, marking the beginning of the spread of the virus across the globe.

ASM American Society of Microbiology COVID-19 Resources

Coronaviruses (CoV), so named for their “crown-like” appearance, are a large family of viruses that spread from animals to humans and include diseases like Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). Researchers have now confirmed that the virus can spread via human-to-human transmission, though the original source of the virus has not been identified. China CDC Weekly. National Health Commission Update March 29, 2020 Confirmed cases: 45 new, 81,439 total.

China CDC Weekly

Suspected cases: 28 new, 174 total. Deaths: 5 new, 3,300 total. Recoveries: 477 new, 75,448 total. Elsevier Novel Coronavirus Information Center. By Margaret Trexler Hessen, MD, Director, Point of Care, Elsevier | Updated March 2, 2020 Novel coronaviruses have emerged as human pathogens in the past, notably associated with outbreaks of SARS (severe acute respiratory syndrome) and MERS (Middle East respiratory syndrome).

Elsevier Novel Coronavirus Information Center

Current investigative methods and recommendations derive in some part from the experience of those epidemics. Diagnosis: Although respiratory infections (including influenza) are prevalent in the northern hemisphere during the winter, clinicians should inquire about travel history and exposure to possible or known COVID-19 in persons presenting with respiratory illness. The possibility of COVID-19 should be suspected in persons who present with compatible clinical illness and exposure history. The US Centers for Disease Control (CDC) and World Health Organization (WHO) developed criteria for whom to test, and these have been modified continually.

Infection control measures are an integral part of management: John Hopkins COVID. Coronaviruses are a family of RNA viruses that typically cause mild respiratory disease in humans.

John Hopkins COVID

A novel coronavirus (COVID-19) was identified in Wuhan, China in December 2019. Our experts are closely following and analyzing updates on this outbreak. The following resources will be routinely updated. CDC COVID-19. WHO-Coronavirus disease 2019. SACYL -COVID-19: recursos y evidencia científica. COVID19 MPR. IDSA Infectious Disease Society of America COVID-19: Resource Center.

American Geriatrics Society COVID 19. For Older Adults & Caregivers COVID-19 is the infectious disease caused by the most recently discovered coronavirus.

American Geriatrics Society COVID 19

Coronaviruses are a large family of viruses that may cause illness in animals or humans. In humans, several coronaviruses are known to cause respiratory infections ranging from the common cold to more severe diseases like COVID-19. COVID-19 illness ranges from mild to severe, though for some it can be deadly. Symptoms usually start 2-14 days after infection. Click here for information from the AGS Health in Aging Foundation. For Health Professionals. American Heart Association COVID. British Thoracic Society COVID. In these extraordinary times we are hearing of many examples of colleagues providing meaningful support to their teams and other colleagues, and systems being put in place for mentoring and leadership beyond usual boundaries.

British Thoracic Society COVID

We also know that social media is proving to be a fertile source of support and sharing of experience. But it is still a concern to many that they are not able to pay attention to their own needs and that resilience sometimes slips. There are several excellent sources of support on-line, and we do not wish to replicate or duplicate. Let us know what you might find helpful, but in the meantime, we have two links below to sites that contain a wealth of wellbeing resources A resource pack produced by the Intensive Care Society for supporting wellbeing is available here. The British Medical Association advice for supporting wellbeing during the COVID-19 pandemic is available here. The NHS wellbeing support website and helpline: 0300 131 7000.

Last update 15/4/20. Fisterra - COVID-19. AHA COVID-19 Resources. Coronavirus disease 2019 (COVID-19) is a respiratory illness that can spread from person to person, which has affected people in many countries. Here are some resources to find more information. The American Heart Association is advising caution and preparation for people who have heart disease or who have survived a stroke. Based on current information, it appears elderly people with coronary heart disease or hypertension are more likely to be infected and to develop more severe symptoms.

Stroke survivors may also face increased risk for complications if they get COVID-19. Video: Coronavirus: What heart and stroke patients need to knowAmerican Heart Association CEO Nancy Brown and Chief Medical Officer for Prevention Eduardo Sanchez, MD, MPH, FAAFP, address many of the questions patients – and all of us – have right now. COVID-2019 SEIMC. SEC acerca del COVID-19 - Sociedad Española de Cardiología. Am College Allergy, Asthma and Immunology. Coronavirus disease 2019 (COVID-19) - UpToDate. Literature review current through: Feb 2020. | This topic last updated: Mar 27, 2020. INTRODUCTION — Coronaviruses are important human and animal pathogens. At the end of 2019, a novel coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in the Hubei Province of China. It rapidly spread, resulting in an epidemic throughout China, followed by an increasing number of cases in other countries throughout the world.

UpToDate. Mapa de Evidencia. Coronavirus PubMed ErnestoB. Búsquedas bibliográficas COVID. COVID Pubmed. COVID-19 Profesionales de Reumatología - SER. The Global Rheumatology Community's response to the worldwide COVID-19 Pandemic. Manual neuroCOVID 19 SEN. CORONAVIRUS COVID-19. Coronavirus (COVID-19) in Scotland. National Collaborating Centre for Methods and Tools. It is critical for public health organizations to work together across jurisdictions during this challenging time and share our efforts in response to COVID-19. To minimize duplication of efforts and facilitate collaboration within public health across Canada, the National Collaborating Centre for Methods and Tools (NCCMT) has collected research questions for rapid evidence reviews currently in development.

Share your Evidence Review Topic Are you or your organization completing evidence reviews on topics related to COVID-19? We encourage you to share your research questions here to reduce duplication and allow collaboration with others across the country. Please complete the submission form and include your contact information. Support for Evidence Reviews For guidance on completing an evidence review, please see the Rapid Review Guidebook. COVID-19. Reorganización de la asistencia. Comunicados. Canadá COVID-19 outbreak updates, symptoms, prevention, travel, preparation. COVID-19 Evidence Alerts from McMaster PLUS.

En Red contra el COVID-19. Beber mucha agua y haga gárgaras con agua tibia, sal y vinagre previene el coronavirus. Covid19. Coronavirus Disease (COVID-19) – Statistics and Research. Mapa interactivo CM. COVID-19. Edición Española – Covid Reference. Covid 19 – Portal Junta Andalucia Covid 19. Preevid: banco de preguntas. COVID-19: An ACP Physician's Guide + Resources (Last Updated April 23, 2020) - Overview. This guide and its collected national resources support physicians as they respond to the Covid-19 pandemic. Use the menu to jump to specific chapters, or read through for a comprehensive overview of care. [This content was last updated on April 23, 2020] The individuals in control of content for this educational activity have nothing to disclose. The following information is derived from clinical guidance collected from national, international, and institutional resources.

Content will undergo revisions as the COVID-19 situation evolves, but all clinicians are cautioned to compare this information against current knowledge and evolving clinical standards specific to their clinical practice locations. UW Medicine COVID-19. Welcome to the UW Medicine COVID-19 Public Site. The clinical and administrative teams throughout our system (Harborview Medical Center, UW Medical Center-Montlake, UW Medical Center-Northwest, Valley Medical Center, UW Neighborhood Clinics and Airlift Northwest) and partners Seattle Cancer Care Alliance have developed policies and protocols in response to the outbreak in Western Washington. Most of these documents have been written since Monday, February 24th 2020 and are undergoing frequent revisions as the COVID-19 situation evolves. When using the documents, we caution you to be mindful of the date the document was produced and to check that against current knowledge and evolving clinical standards.

Since the outbreak began, our colleagues, locally and nationally, have been reaching out to us for assistance as they start to see cases. COVID-19 Society of Hospital Medicine. COVID-19 (Novel Coronavirus) Continuidad al alta SEMFYC Covid19 24 04 2020. SERGAS 30.04 Seguimiento Publicacions COVID19. COVID-END. The COVID-19 pandemic has elicited an explosion of activities among all types of researchers, including in the evidence-synthesis, technology-assessment and guideline-development communities that have long track records of supporting decision-making locally, nationally and internationally. These activities span the full gamut of COVID-19 issues, including traditional infection prevention and control but also how to manage impacts on mental health and family violence, health- and social-care systems, education, employment, financial protection, food safety and security, government services, housing, public safety and justice, recreation and transportation.


RACIONALIZACIÓN RECURSOS. INICIO. Implicaciones CV. Síntomas digestivos. Efectos neurológicos. Efectos dermatológicos. Efectos psiquiátricos. Long Term COVID. Pediatría. JAMA 10.07 Kawasaki like en adultos. MPR 14.10 Síndrome inflamatorio multisistémico en adultos. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection — United Kingdom and United States, March–August 2020. Sapna Bamrah Morris, MD1; Noah G. Schwartz, MD1,2; Pragna Patel, MD1; Lilian Abbo, MD3; Laura Beauchamps, MD3; Shuba Balan, MD3; Ellen H. Lee, MD4; Rachel Paneth-Pollak, MD4; Anita Geevarughese, MD4; Maura K. Lash, MPH4; Marie S. Dorsinville, MPH4; Vennus Ballen, MD4; Daniel P. Eiras, MD4; Christopher Newton-Cheh, MD5,6; Emer Smith, MPH7,8; Sara Robinson, MPH7; Patricia Stogsdill, MD9; Sarah Lim, MBBCh10; Sharon E. View suggested citation Summary What is already known about this topic? Multisystem inflammatory syndrome in children (MIS-C) is a rare but severe complication of SARS-CoV-2 infection in children and adolescents.

What is added by this report? Cases reported to CDC and published case reports and series identify MIS-A in adults, who usually require intensive care and can have fatal outcomes. What are the implications for public health practice? BMJ 03.08 COVID y complicaciones respiratorias a largo plazo. Lung transplantation for patients with severe COVID-19.

Abstract. 29.10 MPR Case Study Reports First Known Case of Neutrophilic Arterial Vasculitis in COVID 19. Jama Newt Open nugent 10.03.2021 Insuf renal aguda tras alta por Covid. 20.04 Medscape Complicaciones renales. Función tiroidea y COVID 29.06. BMJ Case Report Pérdida de audición por COVID Oct. MPR 08.02.21 Some COVID 19 Cases Result in Retinal Vascular Density Decreases, Study Shows Infectious Disease Advisor. 17.04 Medscape Presentaciones atípicas. NEJM 13.05 Tropismo multiorgánico. 01.03.21 NJM Journal Watch Secondary Infections in Patients with Severe COVID 19.

Tormenta de citoquinas

Hipercoagulabilidad. Reactivación - reinfección e inmunidad. TESTS. Factores de riesgo COVID grave. Transmisión. Postpandemia. Mascarillas. Vacunas. Reingreso por COVID. Nueva cepa. NEJM ed 10 sem aplanar curva 01.04. Medscape 30.03 colapso cambio tendencia contagios. MPR Serial Interval of COVID 19 Estimated at 3.96 Days. BMJ personas a riesgo en casa 12 semanas.